ADVANCED ACCELERATOR APPLICATIONS IBERICA SL

Activity

AAA is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging. AAA currently markets 1 targeted radioligand therapy in oncology and several precision imaging products mainly used in clinical oncology, cardiology, neurology and infectious/inflammatory diseases. They also have an active research and development pipeline of investigational drugs using radiolabeled targeting molecules in multiple cancer types.

Corporate Information

Companies from the same group

• SANDOZ INDUSTRIAL PRODUCTS SA

Profile

Manufacturers and Producers

Technologies

• No technology assigned

Products, services and capacities

• 6-Fluoro-[18F]-L-Dopa
• 6-Fluoro-[18F]-L-Dopa
• Drugs
• Drugs and Medicines for Targeted Radioligand Therapy and Precision Radioligand Imaging Lutetium Lu 177 Dotatate / Lutetium (177Lu) Oxodotreotide
• Kit For The Preparation Of Gallium (Ga 68) Edotreotide Solution
• Kit For The Preparation Of Gallium (Ga 68) Edotreotide Solution
• Kit For The Preparation Of Gallium Ga 68 Dotatate Injection
• Kit For The Preparation Of Gallium Ga 68 Dotatate Injection
• Medicines
• Neurology
• Oncology
• [18F]-Choline (FCH)
• [18F]-Choline (FCH)

Applications

• Hospitals and Clinics

Activity classification (NACE)

• 2110 - Manufacture of basic pharmaceutical products

Other information

• Brands: CHOLSCAN, CHOLSCAN, DOPAVIEW, DOPAVIEW, FLUOROCHOL, FLUOROCHOL, LysaKare, LysaKare